Pharmacyte Biotech Inc (PMCB)

Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	32.59% 1.8689	1.4095	2.0753	0.9033	1.553
Operating Income/Loss	32.59% -1.8689	-1.4095	-2.0753	-0.9033	-1.553
Nonoperating Income/Loss	70.25% 1.2494	4.1994	-1.108	0.7769	0.7888
Income/Loss From Continuing Operations Before Tax	122.21% -0.6195	2.7899	-3.1833	-0.1263	-0.7641
Income/Loss From Continuing Operations After Tax	122.21% -0.6195	2.7899	-3.1833	-0.1263	-0.7641
Net Income/Loss	122.21% -0.6195	2.7899	-3.1833	-0.1263	-0.7641
Preferred Stock Dividends And Other Adjustments	5.0006	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.80% 8.607	8.7651	12.60	-0.5624	19.00
Diluted Average Shares	1.80% 8.607	8.7651	12.60	-0.5624	19.00
Basic Earnings Per Share	150.00% -0.65	-0.26	-0.28	-0.01	-0.04
Diluted Earnings Per Share	150.00% -0.65	-0.26	-0.28	-0.01	-0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	5.0006	-	-	-	-